## Management of Pott Disease with Neurological Deficit ### Clinical Context This patient has active Pott disease with: - Radiological evidence of spinal TB (vertebral body destruction, kyphosis, cold abscess) - Early-stage neurological compromise (incomplete paraparesis, grade 4/5) - Systemic signs of TB (fever, elevated inflammatory markers) ### Treatment Algorithm ```mermaid flowchart TD A["Pott Disease with Neurological Deficit"]:::outcome --> B{"Severity of deficit?"}:::decision B -->|"Mild/Incomplete paraparesis"| C["Start ATT immediately"]:::action C --> D{"Neurological deterioration on ATT?"}:::decision D -->|"Yes or progressive"| E["Surgical decompression + fusion"]:::action D -->|"No - stabilization"| F["Continue ATT 12-18 months"]:::action B -->|"Complete paraplegia/acute onset"| G["Urgent surgical decompression"]:::urgent G --> H["Start ATT post-op"]:::action E --> F ``` ### Key Principles **Key Point:** The mainstay of Pott disease management is anti-tuberculous therapy. Surgery is reserved for: 1. **Progressive neurological deficit** despite ATT (4–6 weeks) 2. **Complete paraplegia** with acute onset 3. **Instability** with severe kyphosis (>60°) 4. **Failure to heal** after 18–24 months of ATT **High-Yield:** In this case, the patient has **early/incomplete paraparesis** — ATT should be started immediately. Neurological status is monitored closely. If there is deterioration (worsening weakness, bowel/bladder involvement), then surgical intervention (anterior decompression + fusion or posterior fusion) is indicated. ### Why Surgery Is Not First-Line Here - The deficit is **incomplete** and **progressive over 6 months** (chronic), not acute. - ATT has high success rate (~90%) in halting disease and allowing resorption of abscess. - Surgery carries risk of spinal instability and fusion complications in a TB-infected spine. - Anterior vertebrectomy is reserved for cases with severe kyphosis, instability, or failed ATT. ### Anti-Tuberculous Therapy Regimen - **Intensive phase (2 months):** HRZE (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol) - **Continuation phase (10 months):** HR - **Total duration:** 12–18 months depending on extent **Clinical Pearl:** Vitamin B6 supplementation is mandatory with isoniazid to prevent peripheral neuropathy. Pyrazinamide may cause hyperuricemia and gout flares. **Warning:** Do NOT perform surgery as first-line in incomplete paraparesis — this is a common trap. The spine is infected; fusion without controlling TB leads to implant failure and relapse. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.